Showing results (271-280 of 368) with videos related to

Sort By:
Pageof 37
Circulation|May 23, 2022
Metabolomic Profiling of the Effects of Dapagliflozin in Heart Failure With Reduced Ejection Fraction: DEFINE-HFSenthil Selvaraj, Zhuxuan Fu, Philip Jones, et al.
Circulation|August 7, 2015
Update on Prevention of Cardiovascular Disease in Adults With Type 2 Diabetes Mellitus in Light of Recent Evidence: A Scientific Statement From the American Heart Association and the American Diabetes AssociationCaroline S Fox, Sherita Hill Golden, Cheryl Anderson, et al.
Journal of the American College of Cardiology|March 27, 2024
Dapagliflozin and Days of Full Health Lost in the DAPA-HF TrialToru Kondo, Ulrik M Mogensen, Atefeh Talebi, et al.
JACC. Heart Failure|April 4, 2024
Dapagliflozin and Timing of Prior Heart Failure Hospitalization: A Patient-Level Meta-Analysis of DAPA-HF and DELIVERJawad H Butt, Pardeep S Jhund, Kieran F Docherty, et al.
JAMA Cardiology|January 24, 2024
Dapagliflozin and Mode of Death in Heart Failure With Improved Ejection Fraction: A Post Hoc Analysis of the DELIVER TrialOrly Vardeny, Akshay S Desai, Pardeep S Jhund, et al.
European Journal of Heart Failure|September 20, 2024
In-hospital course of patients with heart failure with improved ejection fraction in the DELIVER trialMaria A Pabon, Muthiah Vaduganathan, Brian L Claggett, et al.
JACC. Heart Failure|September 16, 2022
Influence of NT-proBNP on Efficacy of Dapagliflozin in Heart Failure With Mildly Reduced or Preserved Ejection FractionPeder L Myhre, Muthiah Vaduganathan, Brian L Claggett, et al.
Circulation|November 19, 2019
Efficacy and Safety of Dapagliflozin in Heart Failure With Reduced Ejection Fraction According to Age: Insights From DAPA-HFFelipe A Martinez, Matteo Serenelli, Jose C Nicolau, et al.
European Journal of Heart Failure|January 22, 2022
Dapagliflozin reduces uric acid concentration, an independent predictor of adverse outcomes in DAPA-HFKirsty McDowell, Paul Welsh, Kieran F Docherty, et al.
JACC. Asia|November 7, 2022
Effects of Dapagliflozin in Asian Patients With Heart Failure and Reduced Ejection Fraction in DAPA-HFKieran F Docherty, Inder S Anand, Chern-En Chiang, et al.
Pageof 37